Table 4.
Logistic Regression Analysis of Potential Associations with Line Improvement in BCVA in the Month 2 Analysis Windows
| Parameter | Logistic Regression (Month 2 Analysis Window) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ≥1-Line Improvement | ≥2-Line Improvement | ≥3-Line Improvement | |||||||
| OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Month 2 Analysis Window | |||||||||
| Diagnosis (BRVO versus CRVO) | 1.048 | 0.566–1.941 | 0.881 | 1.102 | 0.596–2.041 | 0.756 | 1.012 | 0.522–1.962 | 0.972 |
| Treatment naivety (naïve versus non-naïve) | 1.783 | 1.069–2.974 | 0.027 | 2.033 | 1.229–3.365 | 0.006 | 2.793 | 1.620–4.816 | <0.001 |
| Age | 0.970 | 0.946–0.994 | 0.015 | 0.970 | 0.947–0.994 | 0.014 | 0.962 | 0.937–0.988 | 0.004 |
| Baseline LogMAR BCVA | 7.650 | 3.410–17.163 | <0.0001 | 9.528 | 4.414–20.568 | <0.0001 | 18.090 | 7.749–42.232 | <0.0001 |
Abbreviations: BCVA, best-corrected visual acuity; BRVO, branch retinal vein occlusion; CI, confidence interval; CRVO, central retinal vein occlusion; LogMAR, Logarithm of the Minimum Angle of Resolution; OR, odds ratio.